World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
56637
World Ranking
5686
National Ranking
125

Yoshiya Tanaka publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yoshiya Tanaka sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,273 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yoshiya Tanaka D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshiya Tanaka sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yoshiya Tanaka is affiliated with the University of Occupational and Environmental Health Japan in Japan. Their research primarily focuses on the field of Medicine, with extensive contributions to subfields such as Rheumatology, Immunology, Genetics, Hematology, and Pathology and Forensic Medicine.

Their recent peer-reviewed publications include the following:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, published in Annals of the Rheumatic Diseases
  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, published in The Lancet Respiratory Medicine
  • Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach, 2022, published in Nature Reviews Rheumatology
  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis, 2022, published in Nature Genetics
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement, 2020, published in Annals of the Rheumatic Diseases

Tanaka's work covers a range of main topics, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Monoclonal and Polyclonal Antibodies Research
  • Lymphoma Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions

The scientist has collaborated frequently with several co-authors, among them:

  • Tsutomu Takeuchi (119 collaborations)
  • Shingo Nakayamada (114 collaborations)
  • Satoshi Kubo (56 collaborations)
  • Yusuke Miyazaki (52 collaborations)
  • Yosuke Okada (51 collaborations)

Regarding publication venues, Tanaka has contributed numerous articles to:

  • Annals of the Rheumatic Diseases (83 publications)
  • Modern Rheumatology (67 publications)
  • Lara D. Veeken (59 publications)
  • Rheumatology and Therapy (33 publications)
  • RMD Open (31 publications)

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    Eric F Morand;Richard Furie;Yoshiya Tanaka;Ian N Bruce

  • T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

    Yoshiya Tanaka;David H. Adams;Stefan Hubscher;Hiroyuki Hirano

  • A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Lymphocyte interactions with endothelial cells.

    Yoji Shimizu;Walter Newman;Yoshiya Tanaka;Stephen Shaw

  • Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

    Peter C. Taylor;Edward C. Keystone;Désirée van der Heijde;Michael E. Weinblatt

  • Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

    Désirée van der Heijde;Yoshiya Tanaka;Roy Fleischmann;Edward Keystone

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

    Daniel J Wallace;Richard A Furie;Yoshiya Tanaka;Kenneth C Kalunian

  • Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes

    Yoshiya Tanaka;David H. Adams;Stephen Shaw

  • Janus kinase inhibitors in autoimmune diseases

    John J O'Shea;Apostolos Kontzias;Kunihiro Yamaoka;Yoshiya Tanaka

  • Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

    Tsutomu Takeuchi;Y. Tatsuki;Y. Nogami;N. Ishiguro

  • Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation

    Yoshiya Tanaka;Shingo Nakayamada;Yosuke Okada

  • CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.

    Y Tanaka;S M Albelda;K J Horgan;G A van Seventer

  • Efficacy of rituximab (Anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

    Mikiko Tokunaga;Kazuyoshi Saito;Daisuke Kawabata;Yoshitaka Imura

  • Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

    Stanley B. Cohen;Yoshiya Tanaka;Xavier Mariette;Jeffrey R. Curtis

  • Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.

    G A van Seventer;W Newman;Y Shimizu;T B Nutman

  • Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

    Yasuo Suzuki;Hajime Nawata;Satoshi Soen;Saeko Fujiwara

  • Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

    Yoshikazu Nakaoka;Mitsuaki Isobe;Syuji Takei;Yoshiya Tanaka

Frequent Co-Authors

Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Hisashi Yamanaka
Hisashi Yamanaka International University of Health and Welfare
Takao Koike
Takao Koike Hokkaido University
Naoki Ishiguro
Naoki Ishiguro Nagoya University
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University
Tsuneyo Mimori
Tsuneyo Mimori Kyoto University
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Takayuki Sumida
Takayuki Sumida University of Tsukuba
Atsushi Kawakami
Atsushi Kawakami Nagasaki University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative or supplementary healthcare pathways? Online nursing degrees offer flexibility and affordability, making them an attractive option. For example, students can explore the cheapest fnp programs online to become advanced practice nurses without breaking the bank.

Cost is a major consideration for many. If you’re wondering how much is online nursing school, top programs now provide competitive tuition rates and various financial aid opportunities.

Ambitious nurses seeking advanced leadership or teaching roles can pursue doctorate in nursing education online programs, opening doors to academic and research careers.

Registered nurses looking for career advancement often choose to complete a bachelor’s degree through the cheapest rn to bsn program, enhancing their skills and job prospects.

Whether starting your journey or advancing your expertise, these affordable online pathways can fast-track your career in healthcare.

Best Scientists Citing Yoshiya Tanaka

Trending Scientists

Recently Published Articles